Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Neuropharmacology. 2012 Mar 23;63(2):190–201. doi: 10.1016/j.neuropharm.2012.03.014

Figure 6.

Figure 6

Daily administration of IVM (1.25 mg/kg/day X 7 days) reduced 10E intake in female C57BL/6J mice using a 24-h access two bottle choice paradigm. After achieving stable drinking levels for 3 consecutive days, IVM was administered for 7 consecutive days. Bars represent levels from the day prior to IVM injections (white; Pre IVM), the 7 day average of the IVM injection (black; IVM) and the day after the IVM injections (gray; Post IVM). Values represented the mean ±SEM for 11 mice. **P<0.01 versus Pre-IVM, Tukey multiple comparison post-hoc test.